newsfilter
← Earnings
Earnings Releases·

Stepan Company — Third Quarter 2026 Earnings Summary

  • Financial Performance:

    • Net sales for the third quarter of 2026 were $692.2 million, a 17% increase year-over-year (YoY) from $590.3 million; year-to-date (YTD) sales were $1,980.8 million, up 11% YoY from $1,778.2 million.
    • Reported net income for Q3 2026 was $17.8 million, up 64% YoY from $10.8 million; YTD net income was a loss of $0.7 million compared to $41.9 million in the prior year.
    • Adjusted net income for Q3 2026 was $21.7 million, up 98% YoY from $10.9 million; YTD adjusted net income was $59.1 million, up 40% YoY from $42.2 million.
    • Earnings per diluted share (EPS) for Q3 2026 were $0.78, up 66% YoY from $0.47; YTD EPS was a loss of $0.03 compared to $1.83 in the prior year.
    • Adjusted EPS for Q3 2026 was $0.94, up 96% YoY from $0.48; YTD adjusted EPS was $2.58, up 40% YoY from $1.84.
    • EBITDA for Q3 2026 was $57.5 million, up 2% YoY from $56.1 million; YTD EBITDA was $110.1 million, down 33% YoY from $164.7 million.
    • Adjusted EBITDA for Q3 2026 was $66.3 million, up 18% YoY from $56.2 million; YTD adjusted EBITDA was $190.3 million, up 15% YoY from $165.1 million.
    • Cash from operations for Q3 2026 was $29.3 million; free cash flow was $8.2 million, negatively impacted by higher working capital requirements.
    • Pre-tax earnings included a $5.6 million restructuring charge in Q3 2026; YTD pre-tax restructuring charges totaled $76.1 million.
    • Total debt decreased by $13.3 million to $634.1 million as of September 30, 2026, compared to $647.4 million on June 30, 2026.
    • Net debt was $536.0 million as of September 30, 2026, with a net debt ratio of 31%, constant with the prior quarter.
  • Guidance and Future Outlook:

    • Management expects to deliver full-year adjusted EBITDA growth in 2026.
    • Management projects positive free cash flow for the full year 2026.
    • Management intends to continue de-leveraging the balance sheet in 2026.
    • The company remains focused on executing growth opportunities, productivity plans, and cash interventions despite ongoing market uncertainties.
  • Business Segments and Product Lines:

    • Surfactants: Net sales were $486.6 million, up 15% YoY; adjusted EBITDA was $48.2 million, up 27% YoY. Global sales volume increased 3% and organic sales volume increased 8%. Double-digit growth occurred in Consumer Products, Construction & Industrial, and Oilfield end markets, partially offset by lower Crop Productivity demand.
    • Polymers: Net sales were $178.7 million, up 24% YoY; adjusted EBITDA was $23.3 million, up 4% YoY. Sales volume increased 3%, with double-digit growth in North American Rigid, Spray Foam, and Phthalic Anhydride businesses, partially offset by lower volumes in Europe and Asia. Regulatory-mandated maintenance turnaround costs at the Germany site were offset by volume growth.
    • Specialty Products: Net sales were $26.9 million, up 12% YoY; adjusted EBITDA was $11.7 million, up 5% YoY. Sales volume increased 20%, driven by the medium chain triglycerides product line, partially offset by less favorable product mix.
    • Project Catalyst: The company executed the organizational redesign phase of Project Catalyst during the quarter, including approximately 100 salaried position reductions (7% of global salaried headcount).
  • Market and Competitive Landscape:

    • Net sales growth was driven by higher selling prices (13% impact in Q3), primarily due to the pass-through of higher raw material costs and pricing actions, alongside volume growth and foreign currency translation.
    • Surfactant selling prices increased 10% YoY; Polymer selling prices increased 22% YoY.
    • The company achieved broad-based volume growth across most end markets despite global economic uncertainties and supply chain disruptions.
    • Foreign currency translation positively impacted Q3 net sales by 1% and negatively impacted Q3 Polymer net sales by 1%.
  • Risks and Challenges:

    • The YTD net loss of $0.7 million was entirely due to a $76.1 million pre-tax restructuring charge.
    • Free cash flow was negatively impacted by higher working capital requirements in the quarter.
    • The company faces ongoing global economic uncertainties and supply chain disruptions.
    • Polymer adjusted EBITDA growth was partially offset by regulatory-mandated maintenance turnaround costs at the Germany site.
    • Specialty Products adjusted EBITDA growth was partially offset by less favorable product mix.
  • Management Commentary and Tone:

    • Luis E. Rojo, President and CEO, stated that quarterly earnings were up significantly driven by improved results in all three segments, global volume growth, margin recovery, and Project Catalyst savings.
    • Management expressed pleasure with growth achieved in key strategic end markets despite market uncertainties.
    • Management noted that Project Catalyst is contributing to growth by optimizing the asset base and creating a more productive and agile organization.
  • Other Key Points:

    • In October 2026, the company closed on the sale of a parcel of land near its Millsdale site for $28.5 million; full cash proceeds will be used to pay down debt.
    • The cash impact associated with the YTD restructuring charge was approximately $12.8 million.
    • Corporate expenses increased 49% YoY in Q3 to $26.2 million, primarily due to the inclusion of restructuring charges, environmental remediation, and deferred compensation; adjusted corporate expenses increased 6% YoY.
    • Environmental remediation expense in Q3 2026 was $2.4 million (after-tax), reflecting a reserve adjustment related to the Maywood, NJ site.
    • Deferred compensation expense in Q3 2026 was $0.1 million (after-tax) compared to $0.1 million income in the prior year.
Company
STEPAN CO
Sector
Basic Materials
Industry
Specialty Chemicals